83_FR_5291 83 FR 5266 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings

83 FR 5266 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 25 (February 6, 2018)

Page Range5266-5267
FR Document2018-02278

Federal Register, Volume 83 Issue 25 (Tuesday, February 6, 2018) 
[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)]
[Notices]
[Pages 5266-5267]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-02278]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group; Biobehavioral and Behavioral 
Sciences Subcommittee.
    Date: March 1, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Downtown DC, 1199 Vermont Avenue, 
Washington, DC 20005.
    Contact Person: Helen Huang, Scientific Review Officer, Division 
of Scientific Review, OD, Eunice Kennedy Shriver National Institute 
of Child Health and Human Development, NIH, DHHS, 6710 Rockledge 
Drive, Bethesda, MD 20892, 301-435-8207, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; Global Network for Women's and 
Children's Health Research: Clinical Research Units.
    Date: March 2, 2018.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Rita Anand, Ph.D., Scientific Review Officer, 
Division of Scientific Review, National Institute of Child Health 
and Human Development, NIH, 6710 Rockledge Drive, Bethesda, MD 
20892, 301-496-1487, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group; Function, Integration, and 
Rehabilitation Sciences Subcommittee.
    Date: March 2, 2018.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW, Washington, DC 20015.
    Contact Person: Joanna Kubler-Kielb, Ph.D., Scientific Review 
Officer, Scientific

[[Page 5267]]

Review Branch, Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, 6710 Rockledge Drive, Bethesda, MD 
20892-7510, 301-435-6916, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group; Pediatrics Subcommittee.
    Date: March 16, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda Downtown, 7335 Wisconsin Ave., 
Bethesda, MD.
    Contact Person: Rita Anand, Ph.D., Scientific Review Officer, 
Division of Scientific Review, National Institute of Child Health 
and Human Development, NIH, 6710 Rockledge Drive, Bethesda, MD 
20892, 301-496-1487, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel.
    Date: March 18, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6710 B Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, 6710 Rockledge Drive, Bethesda, 
MD 20892-9304, (301) 435-6680, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group; Developmental Biology 
Subcommittee.
    Date: March 22, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW, Washington, DC 20015.
    Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review 
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, NIH, DHHS, 
6710 Rockledge Drive, Bethesda, MD 20892, 301-435-6878, 
[email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; Best Pharmaceuticals for 
Children Act Pediatric Trials Network.
    Date: March 28, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6710 B Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, 6710 Rockledge Drive, Bethesda, 
MD 20892-9304, (301) 435-6680, [email protected].

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel.
    Date: March 29-30, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Dennis E. Leszczynski, Ph.D., Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, NIH, 6710 Rockledge Drive, 
Bethesda, MD 20892, (301) 435-6884, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: January 31, 2018.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02278 Filed 2-5-18; 8:45 am]
 BILLING CODE 4140-01-P

5266 Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices amended, notice is hereby given of the Time: 8:00 a.m. to 7:00 p.m. DEPARTMENT OF HEALTH AND following meetings. Agenda: To review and evaluate grant HUMAN SERVICES The meetings will be closed to the applications. public in accordance with the Place: Bethesda North Marriott Hotel & National Institutes of Health provisions set forth in sections Conference Center, 5701 Marinelli Road, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Bethesda, MD 20852. Eunice Kennedy Shriver National as amended. The grant applications and Contact Person: John H. Newman, Ph.D., Institute of Child Health and Human Scientific Review Officer, Center for Development; Notice of Closed the discussions could disclose Scientific Review, National Institutes of Meetings confidential trade secrets or commercial Health, 6701 Rockledge Drive, Room 3222, property such as patentable material, MSC 7808, Bethesda, MD 20892, (301) 435– Pursuant to section 10(d) of the and personal information concerning 0628, newmanjh@csr.nih.gov. Federal Advisory Committee Act, as individuals associated with the grant amended, notice is hereby given of the Name of Committee: AIDS and Related applications, the disclosure of which Research Integrated Review Group; AIDS following meetings. would constitute a clearly unwarranted Molecular and Cellular Biology Study The meetings will be closed to the invasion of personal privacy. Section. public in accordance with the Name of Committee: Center for Scientific Date: March 6, 2018. provisions set forth in sections Review Special Emphasis Panel; Member Time: 8:00 a.m. to 5:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conflict: Addictions, Depression, Bipolar Agenda: To review and evaluate grant as amended. The grant applications and Disorder, and Schizophrenia. applications. the discussions could disclose Date: February 16, 2018. Place: The Westgate Hotel, 1055 Second confidential trade secrets or commercial Time: 8:00 a.m. to 5:00 p.m. Avenue, San Diego, CA 92101. property such as patentable material, Agenda: To review and evaluate grant Contact Person: Kenneth A. Roebuck, applications. and personal information concerning Ph.D., Scientific Review Officer, Center for individuals associated with the grant Place: National Institutes of Health, 6701 Scientific Review, National Institutes of Rockledge Drive, Bethesda, MD 20817 applications, the disclosure of which Health, 6701 Rockledge Drive, Room 5214, (Virtual Meeting). would constitute a clearly unwarranted MSC 7852, Bethesda, MD 20892, (301) 435– Contact Person: Kristin Kramer, Ph.D., 1166, roebuckk@csr.nih.gov. invasion of personal privacy. Scientific Review Officer, Center for Name of Committee: Center for Scientific Name of Committee: National Institute of Scientific Review, National Institutes of Review Special Emphasis Panel; Eukaryotic Child Health and Human Development Initial Health, 6701 Rockledge Drive, Room 5205, Review Group; Biobehavioral and Behavioral MSC 7846, Bethesda, MD 20892, (301) 437– Parasites and Vector. Sciences Subcommittee. 0911, kramerkm@csr.nih.gov. Date: March 6–7, 2018. Date: March 1, 2018. This notice is being published less than 15 Time: 8:00 a.m. to 5:00 p.m. Time: 8:00 a.m. to 5:00 p.m. days prior to the meeting due to the timing Agenda: To review and evaluate grant Agenda: To review and evaluate grant limitations imposed by the review and applications. applications. funding cycle. Place: National Institutes of Health, 6701 Place: Residence Inn Downtown DC, 1199 Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892 Vermont Avenue, Washington, DC 20005. Review Special Emphasis Panel; (Virtual Meeting). Contact Person: Helen Huang, Scientific Biochemistry and Biophysics of Biological Contact Person: Fouad A. El-Zaatari, Ph.D., Review Officer, Division of Scientific Macromolecules Fellowship Applications. Scientific Review Officer, Center for Review, OD, Eunice Kennedy Shriver Date: March 1–2, 2018. Scientific Review, National Institutes of National Institute of Child Health and Time: 11:00 a.m. to 6:00 p.m. Health, 6701 Rockledge Drive, Room 3186, Human Development, NIH, DHHS, 6710 Agenda: To review and evaluate grant MSC 7808, Bethesda, MD 20892, (301) 435– Rockledge Drive, Bethesda, MD 20892, 301– applications. 1149, elzaataf@csr.nih.gov. 435–8207, helen.huang@nih.gov. Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific Name of Committee: National Institute of Rockledge Drive, Bethesda, MD 20892 Review Special Emphasis Panel; Child Health and Human Development (Virtual Meeting). Biomaterials, Delivery, and Nanotechnology. Special Emphasis Panel; Global Network for Contact Person: Sudha Veeraraghavan, Date: March 6–7, 2018. Women’s and Children’s Health Research: Ph.D., Scientific Review Officer, Center for Clinical Research Units. Time: 8:00 a.m. to 5:00 p.m. Scientific Review, National Institutes of Date: March 2, 2018. Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Bethesda, MD Time: 8:30 a.m. to 5:00 p.m. applications and/or proposals. Agenda: To review and evaluate grant 20892, 301–435–1504, Place: Hilton Washington/Rockville, 1750 sudha.veeraraghavan@nih.gov. applications. Rockville Pike, Rockville, MD 20852. Place: Hilton Washington/Rockville, 1750 Name of Committee: Center for Scientific Contact Person: Nitsa Rosenzweig, Ph.D., Rockville Pike, Rockville, MD 20852. Review Special Emphasis Panel; Small Scientific Review Officer, Center for Contact Person: Rita Anand, Ph.D., Business: Cell and Molecular Biology. Scientific Review, National Institutes of Scientific Review Officer, Division of Date: March 6–7, 2018. Health, 6701 Rockledge Drive, Room 4152, Scientific Review, National Institute of Child Time: 8:00 a.m. to 6:00 p.m. MSC 7760, Bethesda, MD 20892, (301) 404– Health and Human Development, NIH, 6710 Agenda: To review and evaluate grant 7419, rosenzweign@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892, 301– applications. 496–1487, anandr@mail.nih.gov. Place: Bethesda Marriott Suites, 6711 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; Name of Committee: National Institute of Democracy Boulevard, Bethesda, MD 20817. 93.333, Clinical Research; 93.306, 93.333, Child Health and Human Development Initial Contact Person: Amy Kathleen Wernimont, 93.337, 93.393–93.396, 93.837–93.844, Review Group; Function, Integration, and Ph.D., Scientific Review Officer, Center for Rehabilitation Sciences Subcommittee. Scientific Review, National Institutes of 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Date: March 2, 2018. daltland on DSKBBV9HB2PROD with NOTICES Health, 6701 Rockledge Drive, Room 6198, Time: 8:30 a.m. to 5:00 p.m. Bethesda, MD 20892, 301–827–6427, Dated: January 31, 2018. Agenda: To review and evaluate grant amy.wernimont@nih.gov. applications. David Clary, Name of Committee: Center for Scientific Place: Embassy Suites at the Chevy Chase Program Analyst, Office of Federal Advisory Review Special Emphasis Panel; PAR Panel: Pavilion, 4300 Military Road NW, Committee Policy. Intervention and Communication for Cancer Washington, DC 20015. Patients, Caregivers, and Communities. [FR Doc. 2018–02275 Filed 2–5–18; 8:45 am] Contact Person: Joanna Kubler-Kielb, Date: March 6, 2018. BILLING CODE 4140–01–P Ph.D., Scientific Review Officer, Scientific VerDate Sep<11>2014 19:02 Feb 05, 2018 Jkt 244001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\06FEN1.SGM 06FEN1

Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices 5267 Review Branch, Eunice Kennedy Shriver Name of Committee: National Institute of 20892, 301–827–7911, lindsay.garvin@ National Institute of Child Health and Child Health and Human Development nih.gov. Human Development, 6710 Rockledge Drive, Special Emphasis Panel. Name of Committee: National Heart, Lung, Bethesda, MD 20892–7510, 301–435–6916, Date: March 29–30, 2018. and Blood Institute Special Emphasis Panel; kielbj@mail.nih.gov. Time: 8:00 a.m. to 5:00 p.m. CLTR Conflict Meeting. Name of Committee: National Institute of Agenda: To review and evaluate grant Date: March 29, 2018. applications. Time: 8:00 a.m. to 3:00 p.m. Child Health and Human Development Initial Place: Residence Inn Bethesda, 7335 Agenda: To review and evaluate grant Review Group; Pediatrics Subcommittee. Wisconsin Avenue, Bethesda, MD 20814. applications. Date: March 16, 2018. Contact Person: Dennis E. Leszczynski, Place: The William F. Bolger Center, 9600 Time: 8:00 a.m. to 5:00 p.m. Ph.D., Scientific Review Administrator, Newbridge Drive, Potomac, MD 20854. Agenda: To review and evaluate grant Division of Scientific Review, National Contact Person: YingYing Li-Smerin, MD, applications. Institute of Child Health and Human Ph.D., Scientific Review Officer, Office of Place: Residence Inn Bethesda Downtown, Development, NIH, 6710 Rockledge Drive, Scientific Review/DERA, National Heart, 7335 Wisconsin Ave., Bethesda, MD. Bethesda, MD 20892, (301) 435–6884, Lung, and Blood Institute, 6701 Rockledge Contact Person: Rita Anand, Ph.D., leszczyd@mail.nih.gov. Scientific Review Officer, Division of Drive, Room 7184, Bethesda, MD 20892– Scientific Review, National Institute of Child (Catalogue of Federal Domestic Assistance 7924, 301–827–7942, lismerin@nhlbi.nih.gov. Health and Human Development, NIH, 6710 Program Nos. 93.864, Population Research; Name of Committee: National Heart, Lung, Rockledge Drive, Bethesda, MD 20892, 301– 93.865, Research for Mothers and Children; and Blood Institute Special Emphasis Panel; 496–1487, anandr@mail.nih.gov. 93.929, Center for Medical Rehabilitation Clinical Trial Pilot Studies (R34). Research; 93.209, Contraception and Date: March 29–30, 2018. Name of Committee: National Institute of Infertility Loan Repayment Program, National Child Health and Human Development Time: 3:00 p.m. to 5:00 p.m. Institutes of Health, HHS) Agenda: To review and evaluate grant Special Emphasis Panel. Date: March 18, 2018. Dated: January 31, 2018. applications. Time: 8:00 a.m. to 5:00 p.m. Michelle Trout, Place: The William F. Bolger Center, 9600 Agenda: To review and evaluate grant Newbridge Drive, Potomac, MD 20854. Program Analyst, Office of Federal Advisory Contact Person: YingYing Li-Smerin, MD, applications. Committee Policy. Place: National Institutes of Health, 6710 B Ph.D., Scientific Review Officer, Office of [FR Doc. 2018–02278 Filed 2–5–18; 8:45 am] Scientific Review/DERA, National Heart, Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). BILLING CODE 4140–01–P Lung, and Blood Institute, 6701 Rockledge Contact Person: Sathasiva B. Kandasamy, Drive, Room 7184, Bethesda, MD 20892– Ph.D., Scientific Review Administrator, 7924, 301–827–7942, lismerin@nhlbi.nih.gov. Division of Scientific Review, National DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance Institute of Child Health and Human HUMAN SERVICES Program Nos. 93.233, National Center for Development, 6710 Rockledge Drive, Sleep Disorders Research; 93.837, Heart and Bethesda, MD 20892–9304, (301) 435–6680, National Institutes of Health Vascular Diseases Research; 93.838, Lung skandasa@mail.nih.gov. Diseases Research; 93.839, Blood Diseases National Heart, Lung, and Blood and Resources Research, National Institutes Name of Committee: National Institute of Institute; Notice of Closed Meetings of Health, HHS) Child Health and Human Development Initial Review Group; Developmental Biology Pursuant to section 10(d) of the Dated: January 31, 2018. Subcommittee. Michelle Trout, Federal Advisory Committee Act, as Date: March 22, 2018. Program Analyst, Office of Federal Advisory Time: 8:00 a.m. to 6:00 p.m. amended, notice is hereby given of the following meetings of the NHLBI Committee Policy. Agenda: To review and evaluate grant Special Emphasis Panel. [FR Doc. 2018–02277 Filed 2–5–18; 8:45 am] applications. Place: Embassy Suites at the Chevy Chase The meetings will be closed to the BILLING CODE 4140–01–P Pavilion, 4300 Military Road NW, public in accordance with the Washington, DC 20015. provisions set forth in sections Contact Person: Cathy J. Wedeen, Ph.D., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND Scientific Review Officer, Division of as amended. The grant applications and HUMAN SERVICES Scientific Review, OD, Eunice Kennedy the discussions could disclose Shriver National Institute of Child Health confidential trade secrets or commercial National Institutes of Health and Human Development, NIH, DHHS, 6710 property such as patentable material, National Eye Institute; Notice of Closed Rockledge Drive, Bethesda, MD 20892, 301– 435–6878, wedeenc@mail.nih.gov. and personal information concerning Meeting individuals associated with the grant Name of Committee: National Institute of applications, the disclosure of which Pursuant to section 10(d) of the Child Health and Human Development Special Emphasis Panel; Best would constitute a clearly unwarranted Federal Advisory Committee Act, as Pharmaceuticals for Children Act Pediatric invasion of personal privacy. amended, notice is hereby given of the Trials Network. Name of Committee: National Heart, Lung, following meeting. Date: March 28, 2018. and Blood Institute Special Emphasis Panel; The meeting will be closed to the Time: 1:00 p.m. to 5:00 p.m. R38: Stimulating Access to Research in public in accordance with the Agenda: To review and evaluate grant Residency (StARR). provisions set forth in sections applications. Date: March 15, 2018. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Institutes of Health, 6710 B Time: 8:00 a.m. to 5:00 p.m. as amended. The grant applications and Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant the discussions could disclose daltland on DSKBBV9HB2PROD with NOTICES (Telephone Conference Call). applications. confidential trade secrets or commercial Contact Person: Sathasiva B. Kandasamy, Place: The William F. Bolger Center, 9600 Ph.D., Scientific Review Administrator, property such as patentable material, Newbridge Drive, Potomac, MD 20854. Division of Scientific Review, National Contact Person: Lindsay M. Garvin, Ph.D., and personal information concerning Institute of Child Health and Human Scientific Review Officer, Office of Scientific individuals associated with the grant Development, 6710 Rockledge Drive, Review, National Heart, Lung, and Blood applications, the disclosure of which Bethesda, MD 20892–9304, (301) 435–6680, Institute, National Institutes of Health, 6701 would constitute a clearly unwarranted skandasa@mail.nih.gov. Rockledge Drive, Suite 7189, Bethesda, MD invasion of personal privacy. VerDate Sep<11>2014 19:02 Feb 05, 2018 Jkt 244001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\06FEN1.SGM 06FEN1


Document Created: 2018-02-06 00:30:43
Document Modified: 2018-02-06 00:30:43
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 1, 2018.
FR Citation83 FR 5266 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR